Preclinical studies predicting low clinical toxicity of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) nimotuzumab
Angel Casacó, Nuris Ledón, Normando Iznaga-Escobar, Maria Elena Arteaga, Tania CrombetVolume:
180
Year:
2008
Language:
english
DOI:
10.1016/j.toxlet.2008.06.117
File:
PDF, 89 KB
english, 2008